Mergers & AcquisitionsBy The Online Investor Staff, updated Sun., Jan. 29, 4:32 PM
|This Slide: #79 of 100|
Slide #79. Cosmos Health, Inc. — Pharmaceutical Laboratories CANA S.A.
Cosmos Health, Inc. (NASDAQ:COSM)
Pharmaceutical Laboratories CANA S.A.
Cosmos Health, Inc. ("the Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today that it has extended and updated its previously issued binding letter of intent to acquire Pharmaceutical Laboratories CANA S.A., ("Cana") a Greek pharmaceutical company that manufactures, sells, distributes, and markets original branded products researched and developed by leading global pharmaceutical and healthcare companies.
Cosmos Health is a pharmaceutical wholesaler. Co. imports, exports and distributes pharmaceutical products of brand-name and generic pharmaceuticals, over-the-counter medicines, and a variety of dietary and vitamin supplements. Most of Co.'s business derives from purchasing and reselling branded pharmaceutical products. Co.'s sales force targets mainly wholesale distributors and other healthcare providers. Co. sells its products principally through independent wholesale distributors, but it also sells directly to other healthcare providers such as; clinics, government agencies, independent retail and pharmacies and independent distributors.
Open the COSM Page at The Online Investor »
Free COSM Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts